Catalyst Wire Dossier Catalyst Wire Dossier

Serotonin and norepinephrine reuptake inhibitor (SNRI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Serotonin and norepinephrine reuptake inhibitor (SNRI), covering 2024-06-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes [Phase 2, Phase 3]

See pricing